Matching slides 16,285
Current window 8,731-8,760
Pages 543
Rows per page 30
Tool: Table Dataclear collectionreset all

Tool

8,731-8,760 of 16,285

filter-aware
13
The slide uses a 5-step process flow diagram to explain the technical methodology.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
Case study slide demonstrating model specificity and performance improvement over existing biological datasets.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
07
The chart uses a horizontal bar representation to indicate progress through discovery and IND-enabling stages.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses two distinct data visualizations: a table for clinical safety metrics and a bar chart for ADA rates.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
06
Includes both GAAP and non-GAAP projections, plus specific product revenue breakdowns.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations 1 hit
19
The slide presents clinical trial baseline data for a very small sample size (N=4).Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
20
The table displays n (%) for adverse events related to the study drug.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
25
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Financials1 hit
26
Includes specific line items for share-based compensation, depreciation, amortization, separation expense, tax effects, non-cash interest, and a Janssen arbitration award.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Financials1 hit
18
Values are in millions (MM).Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
19
The table reconciles Operating Cash Flow to a specific Free Cash Flow metric by subtracting capital expenditures and various lease/financing repayments.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
06
Includes segment-level revenue and expense breakdowns, net income attribution, and EPS calculations.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
08
The table provides a breakdown of revenue and expense components leading to Adjusted Net Income and ANI per share.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
09
Includes footnotes regarding normalization methodology and specific line item adjustments.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
52
The table is split into two sections: financial results and income tax metrics.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
53
Values in millions of Euros (€M).Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
09
The slide uses a comparative structure to justify the strategic shift in trial design post-acquisition.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · ComplicationLoop · Cost Of Inaction1 hit
11
The table displays statistical significance (p-values) for multiple clinical endpoints.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · EvidenceLoop · Jobs To Be Done1 hit
12
TEAE = Treatment-Emergent Adverse Events. Data compares Navacaprant vs Placebo (n=102 each).Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · EvidenceLoop · Jobs To Be Done1 hit
13
Includes a timeline diagram for the randomized, double-blind treatment phase and a summary table of inclusion criteria and endpoints.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
31
Clinical trial baseline characteristics table.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
18
Includes a footnote explaining a change in reconciliation methodology.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Satisfaction1 hit
19
Includes footnotes explaining transaction costs and other adjustments.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Satisfaction1 hit
19
Standard financial disclosure slide for non-GAAP metrics.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
03
This is a standard IPO/follow-on offering summary table.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
26
Rent The Runway | Results Presentation Deck | 32 slidesRent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit
27
The table reconciles cash flow statement figures to actual product acquisition values by adjusting for timing differences in receipt and payment.Rent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit
30
Includes a disclaimer regarding additional information in the Q1 2023 earnings press release.Rent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit
31
Includes GAAP to Non-GAAP reconciliation details.Rent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit
32
Includes both GAAP operating expenses and non-GAAP adjustments for share-based compensation.Rent The Runway | Results Presentation Deck | 32 slides · Rent The Runway
Conference presentation Investor relations 1 hit